In this study, we innovatively developed a fusion prediction model to diagnose EGFR mutations in patients with non-small cell lung cancer by fusing the most widely accepted clinicopathological, radiology, and radiomic features with deep learning features. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.